TORONTO, Nov. 05, 2018 (GLOBE NEWSWIRE) --
Golden Leaf Holdings
Ltd. (âGolden Leafâ or the âCompanyâ) (CSE:GLH) (GLDFF), a cannabis company with cultivation,
production and retail operations built around recognized brands,
today announced financial results for the fiscal third quarter
ended September 30, 2018.
Recent Business and Financial Highlights
Subsequent Events:
Mr. William Simpson, Chief Executive Officer of Golden Leaf Holdings, commented, âOur third quarter revenue reached yet another record, achieving US$5.1 million, primarily driven by sale of flower in Canada after we received our Canadian Sales license from Health Canada, and seasonal improvements in our Oregon Retail revenue and the addition of two new Retail stores in Oregon when compared to the third quarter 2017. Adjusted EBITDA for the third quarter of 2018 was a loss of US$2.9 million primarily driven by production costs and operating expenses.
âCombined with the recent legalization of cannabis in Canada and our ever expanding North American footprint in cultivation, wholesale and retail, we have set the stage for a stronger 2019. We continue our efforts to build our wholesale and retail brands, enhancing trust with our customers, and expanding market share. We are also investing in people and processes as we recognize the importance of a strong, dedicated workforce to support the market growth in the jurisdictions in which we operate,â said Mr. Simpson.
Fiscal Third Quarter Ended September 30, 2018 Financial Results
For the quarter ended September 30, 2018 (âQ3 2018â), net revenue was US$5.1 million as compared to US$3.1 million for the same three-month period in 2017 (âQ3 2017â). The 63% year-over-year increase largely reflects the sale of flower from our Canadian operations, seasonal improvements in Oregon retail, and the addition of two new Chalice Farms stores in Oregon, when compared to the same period in 2017.
Gross profit was US$0.4 million or 9% of net revenue for Q3 2018, compared with US$0.7 million or 23% of net revenue for Q3 2017. Q3 2018 gross margins decreased primarily due to non-cash valuation of biological assets. As of September 30, 2018, biological assets were newly planted and on average 13% complete.
Operating expenses were US$4.7 million USD for Q3 2018, consistent with US$4.7 million in Q3 2017.
Adjusted EBITDA loss was US$2.9 million for Q3 2018, a slight improvement compared with a loss of US$3.0 million for Q3 2017, primarily as a result of an increase in product sales volume. Adjusted EBITDA is defined by the Company as earnings before taxes, depreciation and amortization, less certain non-cash equity compensation expenses, including impairments, one-time transaction fees and all other non-cash items. The Company considers Adjusted EBITDA an important operational measure for the business.
Net loss for Q3 2018 was US$5.5 million or US$0.01 per share loss, compared with a net loss of US$3.2 million or US$0.01 per share loss, for Q3 2017. Net loss for Q3 2018 increased primarily attributed to the effect of the changes in fair value of non-cash assets and debt, specifically, biological assets and warrant liability.
As of September 30, 2018, the Company had approximately US$20.1 million in current assets, compared with US$11.6 million in current assets at December 31, 2017. The increase is largely because of the bought deal financing which was completed on January 31, 2018, in addition to proceeds from warrant exercises. Total assets increased to US$84.2 million at September 30, 2018, compared to US$75.8 million at December 31, 2017, also due primarily to the bought deal financing completed in January.
Investor Conference Call
Golden Leaf, led by William Simpson, Chief Executive Officer, will hold a conference call at 4:30 PM ET today, Monday, November 5th, 2018, to report its financial results for the third quarter ended September 30, 2018.
The dial-in information for the conference call is as follows:
Program Title: Golden Leaf Holdings Third Quarter 2018 Financial Results Call
Canada & U.S.: (877)
423-9813
International: (201) 689-8573
Participants must request the Golden Leaf Holdings Call.
A live audio webcast will be available online on Golden Leaf's website at goldenleafholdings.com, where it will be archived for two weeks.
An audio replay of the conference call will be available through midnight November 19, 2018 by dialing +1 (844) 512-2921 from the U.S. or Canada, or +1 (412) 317-6671 from international locations, Conference ID: 13684932
To be added to the Golden Leaf email distribution list, please email [email protected] with "GLH" in the subject line.
About Golden Leaf Holdings
Golden Leaf Holdings Ltd. is a Canadian company with operations in
multiple jurisdictions including Oregon, Nevada and Canada, with
cultivation, production and retail operations built around
recognized brands. Golden Leaf distributes its products through its
branded Chalice Farms retail dispensaries, as well as through
third-party dispensaries. Golden Leafâs cannabis retail operations
and products are designed with the customer in mind, focused on
superlative in-store experience and quality products. Visit
goldenleafholdings.com to learn more.
Investor Relations: Craig Eastwood Chief Financial Officer Golden Leaf Holdings Ltd. 503-201-0659 [email protected] |
Media Relations: Anne Donohoe / Nick Opich KCSA Strategic Communications [email protected]/[email protected] 212-896-1265 / 212-896-1206 |
Disclaimer: This press release contains
"forward-looking information" within the meaning of applicable
securities legislation. Forward-looking information includes, but
is not limited to, statements with respect to the Companyâs future
business operations, the establishment of, and the future scope and
scale of, the Chalice Farms retail system, the level of funding
needed to establish the Chalice Farms franchise model, that the
Chalice Farms franchise model will be successful and generate
positive cash flows, the opinions or beliefs of management and
future business goals. Generally, forward looking information can
be identified by the use of forward-looking terminology such as
"plans", "expects" or "does not expect", "is expected", "budget",
"scheduled", "estimates", "forecasts", "intends", "anticipates" or
"does not anticipate", or "believes", or variations of such words
and phrases or state that certain actions, events or results "may",
"could", "would", "might" or "will be taken", "occur" or "be
achieved". Forward-looking information is subject to known and
unknown risks, uncertainties and other factors that may cause the
actual results, level of activity, performance or achievements of
the Company to be materially different from those expressed or
implied by such forward-looking information, including but not
limited to general business, economic and competitive
uncertainties, regulatory risks including risks related to the
expected timing of the Companyâs participation in the adult use
market, market risks, risks inherent in manufacturing operations,
difficulties of establishing a successful franchise model and other
risks of the cannabis industry. Although the Company has attempted
to identify important factors that could cause actual results to
differ materially from those contained in forward-looking
information, there may be other factors that cause results not to
be as anticipated, estimated or intended. There can be no assurance
that such information will prove to be accurate, as actual results
and future events could differ materially from those anticipated in
such statements. Accordingly, readers should not place undue
reliance on forward looking information. Forward-looking
information is provided herein for the purpose of presenting
information about managementâs current expectations relating to the
future and readers are cautioned that such information may not be
appropriate for other purpose. The Company does not undertake to
update any forward-looking information, except in accordance with
applicable securities laws. This press release does not constitute
an offer of securities for sale in the United States, and such
securities may not be offered or sold in the United States absent
registration or an exemption from registration or an exemption from
registration.